Aytu BioScience, Inc. (NASDAQ:AYTU) Q2 2020 Earnings Conference Call February 13, 2020 4:30 PM ET Company Participants Josh Disbrow – Chairman and Chief Executive Officer Dave Green – Chief Financial Officer Conference Call Participants Carl Byrnes – Northland Securities Jeffrey Cohen – Ladenburg Thalmann Operator Good afternoon and thank you for joining us for the Aytu BioScience Second Quarter Fiscal 2020 Business Update Call for the Quarter Ended December 31, 2019. With me this afternoon are Aytu's Chair ...

Aytu BioScience, Inc. (NASDAQ:AYTU) Q1 2020 Earnings Conference Call November 14, 2019 4:30 PM ET Company Participants Joshua Disbrow - Chairman & CEO David Green - CFO, Secretary & Treasurer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann & Co. Carl Byrnes - Northland Capital Markets Operator Good afternoon, everyone, and thank you for joining us for the Aytu BioScience First Quarter Fiscal 2020 Business Update Call. With me this afternoon are Aytu's Chairman and Chief Executive Officer, Jo ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 per share AYTU The NASDAQ Stock Market LLC FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended: September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commis ...

Aytu BioScience, Inc. (NASDAQ:AYTU) Commercial Portfolio Acquisition Overview Conference Call October 14, 2019 4:30 PM ET Company Participants Josh Disbrow - Chairman and Chief Executive Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Carl Byrnes - Northland Capital Markets Operator Good afternoon, everyone, and thank you for joining us for this Conference Call discussing Aytu BioScience’s Announced Acquisition of a Six Product Commercial Portfolio. With me this afternoon to discuss ...

Aytu BioScience, Inc. (NASDAQ:AYTU) Q4 2019 Earnings Conference Call September 26, 2019 4:30 PM ET Company Participants Josh Disbrow - Chairman & Chief Executive Officer David Green - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann & Co. Inc. Carl Byrnes - Northland Capital Markets Operator Good morning, everyone. Thank you for joining us for the Aytu BioScience’s Year-End and Fourth Quarter Business Update Call for the Year-Ended June 30, 2019. With me this afternoon ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 333-146542 | --- | --- | |--------------------------------------------------------------------|-------------------------------------------| | Delaware | 47-0883144 | | (State or ...

Aytu BioScience, Inc. (NASDAQ:AYTU) Q3 2019 Earnings Conference Call May 14, 2019 9:00 AM ET Company Participants Josh Disbrow - Chairman and Chief Executive Officer David Green - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann & Co. Inc. Carl Byrnes - Northland Securities, Inc. Operator Good morning, everyone. Thank you for joining us for the Aytu BioScience Third Quarter Fiscal 2019 Business Update Call. With me this morning are Aytu's Chief Executive Officer, Josh ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended: March 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-38247 AYTU BIOSCIENCE, INC. (www.aytubio.com) | --- | --- | |---------------------|-------| | | | | | | | | | | | | | | | | | | | | | | (IRS ...

Aytu BioScience, Inc. (NASDAQ:AYTU) Q2 2019 Earnings Conference Call February 7, 2019 9:00 AM ET Company Participants Josh Disbrow - Chief Executive Officer Dave Green - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Carl Byrnes - Northland Operator Good afternoon, everyone. Thank you for joining us for the Aytu BioScience Second Quarter Fiscal 2019 Business Update Call. With me this afternoon are Aytu's Chief Executive Officer, Josh Disbrow; Chief Financial Officer, ...